Navigation Links
Varian Medical Systems to Exhibit X-ray and CT Technologies for Non-Destructive Testing at the Upcoming ASNT 18th Annual Spring Conference
Date:3/13/2009

ST. LOUIS, March 13 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) will exhibit X-ray and computed tomography (CT) products for the non-destructive testing market at the upcoming ASNT Research Symposium and Spring Conference taking place March 16-20, 2009 at the Millennium Hotel in St. Louis, MO.

The company will exhibit a number of products at the conference including:

  • A new computed tomography system, the BIR 500-450/225, capable of operating in volumetric (cone-beam) CT, helical volume CT, and real-time radiographic imaging modes. This system offers high-speed distributed reconstruction, providing dramatically improved image reconstruction performance on large volume data sets.
  • A line of high KV X-ray tube sources for non-destructive inspection (NDI), including the new Beryllium (Be) window NDI 451 X-ray tube, for inspection of castings for automotive, aerospace, and other industrial applications. The new Beryllium window NDI 451 tube can be used at energy levels ranging between 75kV and 450kV. The Beryllium window NDI 451 is highly efficient and features a very low filtration value, allowing more X-rays to be generated at lower energies than is possible with the standard Iron (Fe) window version of the NDI 451 tube.

Varian Medical Systems, through its Security & Inspection Products business, is the market leader in high-energy X-ray linear accelerators for non-destructive testing and cargo screening applications. Varian is also the world's largest independent supplier of X-ray tubes and flat-panel digital X-ray image detectors for medical and industrial applications. To find out more about Varian Medical Systems and our wide array of X-ray products for non-destructive testing, please visit our booth at the ASNT Spring Conference, or visit www.varian.com.

About Varian Medical Systems

Varian Medical Systems, Inc. is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. Varian is also a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America, Europe, and China and approximately 60 sales and support offices around the world. For more information, visit http://www.varian.com.

    FOR INFORMATION CONTACT:

    Meryl Ginsberg, (650) 424-6444
    meryl.ginsberg@varian.com

    Elaine Fairless, (801) 978-5715
    elaine.fairless@varian.com


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network
2. Varian Medical Systems Exhibits Latest Technologies and Products Designed to Improve Speed and Precision of Radiotherapy at ESTRO 2007
3. Varian Medical Systems Receives FDA 510(k) Clearance for High-Definition Collimator That Enables Ultra-Fine Intensity-Modulated Radiosurgery
4. Bavarian Nordic Receives $50 Million Advance Payment from HHS for Fulfilling Contract Milestones
5. Varian Medical Systems Introduces New and Improved VariSeed(TM) 8.0 Software for Permanent Seed Prostate Brachytherapy Treatments
6. New SPE Cation Exchange Technology From Varian Simplifies Extraction of Basic Compounds
7. Varian Medical Systems Sponsors Special Broadcast of The Group Room(R), a Live Radio Talkshow About Cancer
8. Varian, Inc. Reports First Quarter 2008 Results
9. deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women
10. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
11. New Chromatography Detectors From Varian, Inc. Extend the Range of Universal Detection for HPLC and LC/MS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017  GlobeImmune, Inc. today announced it has ... of 12,835,490 shares of its common stock to NantCell, ... connection with the sale of its common stock, NantCell ... issue to GlobeImmune 200,000 shares, an estimated $2.0 million ... "We are pleased to enter into this strategic agreement ...
(Date:3/23/2017)... March 23, 2017 NetworkNewsWire Editorial Coverage  ... Cancer ... significant strain on health care systems, in terms of costs ... so too does the development of innovative and efficient therapies ... Among the many types of cancer treatments, a growing number ...
(Date:3/23/2017)... ... March 23, 2017 , ... Advanced Polymer Monitoring Technologies ... Dr. Sigmund “Sig” Floyd as Vice President ? Global Business Development. Dr. Floyd ... , “Dr. Floyd’s career has spanned 30 years in the chemicals and equipment ...
(Date:3/22/2017)... 2017  UBM and the Massachusetts Medical Device ... partnership and the third annual Massachusetts Medtech Week. Massachusetts ... st Annual MassMEDIC Conference held in conjunction ... 2017. MassMEDIC will feature a ... and CEO, Scott Whitaker , at its ...
Breaking Biology Technology:
(Date:2/27/2017)... --  Strategic Cyber Ventures , the industry,s first cybersecurity ... million investment in  Polarity , the first commercial human ... based and is led by cybersecurity veterans Tom ... Gula , also a longtime cybersecurity veteran and founder ... A round of funding. This new funding will be ...
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis ... Gespräch mit mehr als 50 Vertretern aus verschiedenen Branchen wurde ... um diese Prognose zu realisieren. ... Zu den Schwierigkeiten ... Mittel für die Biobank, die Implementierung Zeit sparender Technologien, ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):